Analystreport

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Smith Barney Citigroup from $625.00 to $675.00.

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report